[1] 刘鹏, 韩琴琴, 杨毅, 杨英珍. 胰岛素样生长因子-1在高脂血症发病中的意义 [J]. 中国实用内科杂志 2002.doi:10.3969/j.issn.1005-2194.2002.04.008
[2] 孙前进, 梁岩, SUN Qian-jin, LIANG Yan. 易损斑块的研究进展 [J]. 医学综述 2009.doi:10.3969/j.issn.1006-2084.2009.04.028
[3] 周俊, 陆国平. 动脉粥样硬化斑块的临床检测 [J]. 中国动脉硬化杂志 2002.doi:10.3969/j.issn.1007-3949.2002.02.027
[4] Naghavi, M, Libby, P, Falk, E, Casscells, SW, Litovsky, S, Rumberger, J, Badimon, JJ, Stefanadis, C, Moreno, P, Pasterkamp, G, Fayad, Z, Stone, PH, Waxman, S, Raggi, P, Madjid, M, Zarrabi, A, Burke, A, Yuan, C, Fitzgerald, PJ, Siscovick, DS, de-Korte, CL, Aikawa, M, , Juhani, , . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. [J]. Circulation 2003, 14(14).
[5] Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P. [J]. Journal of Molecular and Cellular Cardiology 2001.
[6] González-Timón B, González-Mu(n)z M, Zaragoza C. Native and oxidize low density lipoproteins oppositely modulate the effects of insulin-like growth factor 1 on VSMC [J]. Cardiovascular Research 2004, 61(02).
[7] Pascual M., Martinez JA., Larralde J.. INSULIN-LIKE GROWTH FACTOR I (IGF-I) AFFECTS PLASMA LIPID PROFILE AND INHIBITS THE LIPOLYTIC ACTION OF GROWTH HORMONE (GH) IN ISOLATED ADIPOCYTES [J]. Life sciences 1995, 12(12).
[8] Oscarsson J, Lundstam U, Gustafsson B. Recombinant human insulin-like growth factor-1 decreases serum lipoprotein (a) concentrations in normal adult men [J]. Clinical Endocrinology(Oxford) 1995, 42(06).
[9] Loree H M, Tobias B J, Gilbson L J. Mechanical properties of model atherosclerotic lesion lipid pools [J]. Arteriosclerosis and Thrombosis 1994, 14(02). |
